BIO

NYSEStock

Bio-Rad Laboratories, Inc.

$261.81-8.08 (-2.99%)

52-Week Range

$216.56

$339.75

Key Stats

Market Cap

7.1B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.20

Volume

232.6K

Avg Volume

280.7K

Performance

-10.85%

-14.97%

-6.56%

YTD

-14.23%

+6.86%

-46.84%

-54.03%

Price Chart

ETF Exposure

BIO is held by 163 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
AOK	iShares Core 30/70 Conservative Allocation ETF	0.00%	39	$11K	$733.2M	0.20%
AOM	iShares Core 40/60 Moderate Allocation ETF	0.00%	120	$32K	$1.69B	0.20%
AOR	iShares Core 60/40 Balanced Allocation ETF	0.00%	348	$93K	$3.28B	0.20%
EAOK	iShares ESG Aware 30/70 Conservative Allocation ETF	0.00%	0	$104	$9.0M	0.30%
EAOM	iShares ESG Aware 40/60 Moderate Allocation ETF	0.00%	0	$128	$8.3M	0.31%
EAOR	iShares ESG Aware 60/40 Balanced Allocation ETF	0.00%	3	$697	$30.3M	0.32%
IRTR	iShares LifePath Retirement ETF	0.00%	4	$1K	$52.3M	0.08%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	5	$1K	$61.4M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	9	$2K	$81.5M	0.10%
LVHB	Innovator Laddered Allocation Power Buffer ETF	0.00%	161	$75K	$782.6M	0.10%
FTLS	First Trust Long/Short Equity ETF	0.00%	0	$0	$2.16B	1.38%
IQSM	NYLI Candriam U.S. Mid Cap Equity ETF	0.00%	1,654	$0	$207.8M	0.15%
MMTM	State Street SPDR S&P 1500 Momentum Tilt ETF	0.00%	2	$535	$163.7M	0.12%

PreviousPage 4 of 4

About BIO ETF Exposure

Bio-Rad Laboratories, Inc. (BIO) is held by 163 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 7.1B, BIO is a widely held institutional stock. The stock currently trades at $261.81. Investors can gain exposure to BIO through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold BIO, sorted by portfolio weight.